Literature DB >> 24876592

Current Trends in Continuous Glucose Monitoring.

Volker Lodwig1, Bernhard Kulzer2, Oliver Schnell3, Lutz Heinemann4.   

Abstract

The market introduction of systems for continuous glucose monitoring (CGM) some 15 years ago did not immediately revolutionize the treatment of diabetes; however, for a given group of patients, it would almost be inconceivable nowadays to imagine life without CGM. One day the development of insulin pumps together with CGM could culminate in an artificial pancreas system. The performance of the glucose sensors used for glucose measurement in the interstitial fluid in the subcutaneous tissue and the algorithms employed to analyze these data have improved so much over the past decade that current CGM systems by far outperform those of the first generations. This commentary discusses a number of aspects about what we have learned since CGM systems entered the market and what current trends exist in their usage. Some of these are major hurdles facing a more widespread usage of CGM.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  artificial pancreas; continuous glucose monitoring; diabetes therapy; glucose sensors; hypoglycemia; quality of life

Year:  2014        PMID: 24876592      PMCID: PMC4455393          DOI: 10.1177/1932296814525826

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

1.  Continuous glucose monitoring: quality of hypoglycaemia detection.

Authors:  E Zijlstra; T Heise; L Nosek; L Heinemann; S Heckermann
Journal:  Diabetes Obes Metab       Date:  2012-09-20       Impact factor: 6.577

2.  The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.

Authors:  Ignacio Conget; Tadej Battelino; Marga Giménez; Hannah Gough; J Castañeda; Jan Bolinder
Journal:  Diabetes Technol Ther       Date:  2011-01       Impact factor: 6.118

3.  Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.

Authors:  Lalantha Leelarathna; Marianna Nodale; Janet M Allen; Daniela Elleri; Kavita Kumareswaran; Ahmad Haidar; Karen Caldwell; Malgorzata E Wilinska; Carlo L Acerini; Mark L Evans; Helen R Murphy; David B Dunger; Roman Hovorka
Journal:  Diabetes Technol Ther       Date:  2012-12-20       Impact factor: 6.118

4.  ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.

Authors:  David C Klonoff; Richard M Bergenstal; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew Ahmann; John B Welsh; Scott W Lee
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

5.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

6.  Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Authors:  Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman
Journal:  N Engl J Med       Date:  2013-06-22       Impact factor: 91.245

Review 7.  Continuous glucose monitoring systems for type 1 diabetes mellitus.

Authors:  Miranda Langendam; Yoeri M Luijf; Lotty Hooft; J Hans Devries; Aart H Mudde; Rob J P M Scholten
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

8.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Authors:  John C Pickup; Suzanne C Freeman; Alex J Sutton
Journal:  BMJ       Date:  2011-07-07

9.  Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.

Authors:  Robert A Vigersky; Stephanie J Fonda; Mary Chellappa; M Susan Walker; Nicole M Ehrhardt
Journal:  Diabetes Care       Date:  2011-11-18       Impact factor: 19.112

10.  Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept.

Authors:  Andrea Facchinetti; Giovanni Sparacino; Stefania Guerra; Yoeri M Luijf; J Hans DeVries; Julia K Mader; Martin Ellmerer; Carsten Benesch; Lutz Heinemann; Daniela Bruttomesso; Angelo Avogaro; Claudio Cobelli
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112

View more
  10 in total

1.  Designing an artificial pancreas architecture: the AP@home experience.

Authors:  Giordano Lanzola; Chiara Toffanin; Federico Di Palma; Simone Del Favero; Lalo Magni; Riccardo Bellazzi
Journal:  Med Biol Eng Comput       Date:  2014-11-28       Impact factor: 2.602

2.  SPECTRUM.

Authors:  Bernhard Gehr; Martin Holder; Bernhard Kulzer; Karin Lange; Andreas Liebl; Claudia Sahm; Simone von Sengbusch; Sandra Schlüter; Thorsten Siegmund; Ulrike Thurm; Ralph Ziegler; Guido Freckmann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2016-08-20

3.  Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications.

Authors:  Martina Vettoretti; Giacomo Cappon; Giada Acciaroli; Andrea Facchinetti; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2018-05-22

4.  Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.

Authors:  Bing Gu; Diane J Burgess
Journal:  Int J Pharm       Date:  2015-09-15       Impact factor: 5.875

5.  Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus.

Authors:  T Battelino; S Liabat; H J Veeze; J Castañeda; A Arrieta; O Cohen
Journal:  Diabet Med       Date:  2015-07-14       Impact factor: 4.359

6.  Decreased complexity of glucose dynamics preceding the onset of diabetes in mice and rats.

Authors:  Xiaohua Douglas Zhang; David Pechter; Liming Yang; Xiaoli Ping; Zuliang Yao; Rumin Zhang; Xiaolan Shen; Nina Xiaoyan Li; Jonathan Connick; Andrea R Nawrocki; Manu Chakravarthy; Cai Li
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

7.  Rapid, low cost prototyping of transdermal devices for personal healthcare monitoring.

Authors:  Sanjiv Sharma; Anwer Saeed; Christopher Johnson; Nikolaj Gadegaard; Anthony Eg Cass
Journal:  Sens Biosensing Res       Date:  2017-04

8.  Real-time intradermal continuous glucose monitoring using a minimally invasive microneedle-based system.

Authors:  Federico Ribet; Göran Stemme; Niclas Roxhed
Journal:  Biomed Microdevices       Date:  2018-12-06       Impact factor: 2.838

Review 9.  Functionalized microneedles for continuous glucose monitoring.

Authors:  Kai Takeuchi; Beomjoon Kim
Journal:  Nano Converg       Date:  2018-10-24

Review 10.  Self-measurement of Blood Glucose and Continuous Glucose Monitoring - Is There Only One Future?

Authors:  Lutz Heinemann; Andreas Stuhr; Adam Brown; Guido Freckmann; Marc D Breton; Steven Russell; Lutz Heinemann
Journal:  Eur Endocrinol       Date:  2018-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.